在一个复合反应元件的非受体因子区分的矿物质皮质醇和葡萄皮质醇受体活性
1Department of Biochemistry and Biophysics, University of California, San Francisco 94143-0448.
概括
葡萄糖皮质体受体 (GR) 抑制复合元素的转录,而矿物质皮质体受体 (MR) 则没有. 特定的GR区域是这种独特活动的关键,影响激素介导的生理反应.
科学领域:
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
- 基因调节 基因调节
背景情况:
- 矿物质皮质体受体 (MR) 和葡萄糖皮质体受体 (GR) 介导着不同的生理效应.
- 这两种受体从简单的激素反应元素 (HREs) 类似地结合和激活转录.
研究的目的:
- 分析MR和GR在复合响应元件 (plfG) 的差异性活动.
- 确定负责差异转录调节的受体域.
主要方法:
- 对plfG复合反应元件的GR和MR活性进行分析.
- 使用矿物质皮质体受体-葡萄皮质体受体 (MR-GR) 嵌合体来绘制功能域的地图.
主要成果:
- 在相同的条件下,GR抑制了plfG的AP1刺激转录,而MR则不活跃.
- 对于这种压制性活动,GR的一个特定的N端区域 (氨基酸105-440) 是必不可少的.
结论:
- 在由特定受体域介导的复合反应元素中,与非受体因子的差异性相互作用可能决定了MR和GR的独特生理效应.
- 了解这些特定领域的相互作用对于破译激素作用至关重要.
更多相关视频
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Cross-reactivity
Overview
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
